We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 491

The Court of Appeal sends s.8 case back to trial judge for redetermination

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 26 2012

The Federal Court of Appeal (FCA) has granted Apotex’ appeal and sent a case considering s. 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations) back to the Trial Judge for redetermination

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 1 2012

Health Canada has announced revisions to the Draft Guidance Document: The Use of Foreign Reviews by Health Canada and revisions to the Use of Foreign Reviews pilot project

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 20 2011

The Canadian Intellectual Property Office indicated that broader accessibility to patent prosecution highway agreements will be provided as part of a one-year pilot project

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 27 2010

The Government has published amendments to the Patented Medicines (Notice of Compliance) Regulations

New affidavit struck from record in judicial review

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 6 2012

This is an interlocutory motion to strike an affidavit in a Judicial Review (JR) of the decision of the Copyright Board

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • November 28 2011

Health Canada has published a web info sheet on drug shortages

Final amount for section 8 damages determined

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 12 2012

The Court had previously provided a judgment, resolving a number of matters in dispute between the parties with respect to the amount of compensation to be paid pursuant to s. 8 of the NOC Regulations (summary here

Court of Appeal refuses to reinstate patent when fees paid by someone other than the authorized agent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 24 2011

This is an appeal of a judgment dismissing an application for a judicial review of a decision of the Commissioner of Patents

Pfizer Canada Inc. v. Novopharm, The Minister of Health, Northwestern University and the Board of Regents for the University of Oklahoma

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

In a proceeding pursuant to the Patented Medicines (Notice of Compliance) Regulations, Novopharm brought a motion seeking a Protective Order that allowed the designation of Novopharm's Notice of Allegation (NOA) as confidential

Appeal of TMOB refusal to grant trade-mark dismissed by federal court

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 9 2013

In this case, Societe Anonyme appealed the decision of the Trade-Marks Opposition Board (TMOB) refusing its trade-mark application for “MONTE-CARLO BEACH HOTEL”. The Court considered issues relating to an alleged defect in the chain of title, distinctiveness, the extent to which the trade-marks are known, the length of time the trade-